Lannett (LCI) Soars 10.1%: Is Further Upside Left in the Stock?
Lannett (LCI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Advair Diskus Respirent Pharmaceuticals Zacks Investment Research Zacks Rank Strong Buy Zacks Investment
Source: yahoo.com